Specific biologics and side effects
| Target | Action | Drug | Condition | Route | Other side effects |
|---|---|---|---|---|---|
| Anti-TNF | Blocks TNF | Etanercept
Infliximab Adalimumab Certolizumab Golimumab |
RA, AS, PsA | Infliximab IV
Others SC |
Injection site reaction, hypersensitivity, heart failure*, demyelination*, lupus-like syndrome, reactivation of TB** |
| Anti CD20 | Depletes B cells | Rituximab | RA, GPA, MPA | Anaphylaxis, skin reaction | |
| Anti BLyS/BAFF | Depletes B cells | Belimumab | SLE | IV | Depression, hypersensitivity |
| IL-1 receptor antagonist | Blocks interleukins | Anakinra | RA, Still’s disease | SC (daily) | Injection site reactions |
| IL-6 receptor antagonist (JAK inhibitor) | Blocks interleukins | Tocilizumab | RA, GCA | IV or SC | Dyslipidaemia, hepatitis, skin reaction, hypersensitivity |
| IL-12/23 antagonist | Reduces Th17 cell activation | Ustekinumab | PsA | SC | Skin reaction, facial palsy |
| IL-17A antagonist | Reduces Th17 cell activation | Secukinumab | AS, PsA | SC | IBD exacerbation |
| CTLA4-Ig | Disrupts T-cell activation | Abatacept | RA, PsA | IV or SC | Hypersensitivity |
Table 3 Examples of different sub-classes of biologic, their uses, route of administration and side effects
*TNF inhibitors should not be prescribed in those with multiple sclerosis or severe heart failure (NYHA grade 3-4)
**Mainly with infliximab and adalimumab
Take your subscriptions with you
Our mobile app allows you to access your interview and exam question banks wherever you are.